5112, David Geffen School of Medicine at UCLA Clinical Research Site — Los Angeles, California

5112, David Geffen School of Medicine at UCLA Clinical Research Site is a clinical research site located in Los Angeles, California, United States 90095-1752.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

5112, David Geffen School of Medicine at UCLA Clinical Research Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 5112, David Geffen School of Medicine at UCLA Clinical Research Site?

5112, David Geffen School of Medicine at UCLA Clinical Research Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 5112, David Geffen School of Medicine at UCLA Clinical Research Site conducted?

5112, David Geffen School of Medicine at UCLA Clinical Research Site has 1 clinical trials on record, with 1 currently active. Their work covers HIV Infection.

Is 5112, David Geffen School of Medicine at UCLA Clinical Research Site accredited by Crixeo Health?

5112, David Geffen School of Medicine at UCLA Clinical Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 5112, David Geffen School of Medicine at UCLA Clinical Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.